Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

DocGo Inc. ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the acquisition of PTI Health, a mid-Atlantic mobile lab collection and ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Q1 2025 Earnings Call Transcript February 6, 2025 Embecta Corp. beats earnings expectations. Reported EPS is $0.65, ...

Donald Trump plans to make it legal for businesses to bribe foreign officials.

The two men’s history together runs deeper than politics: Blajogevich, commonly known as “Blago,” appeared on Trump’s reality ...

TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

Sen. FETTERMAN on Trump saying the US will "take over" the Gaza strip and relocate all Palestinians while area is rebuilt: ...

A high school quarterback and UNC Tar Heel fan, Noah Gray overcame Type 1 diabetes to star for the Duke Blue Devils before ...

Circadian rhythm fasting may boast a few benefits, like helping improve body composition, sleep, and more. But is it worth ...

Arrowhead Pharmaceuticals, Inc. ( NASDAQ: ARWR) Q1 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Chris Anzalone - President & CEO Bruce Given - Interim Chief Medical Scientist Andy Davis ...